ATAI Life Sciences's market cap is currently ―. The company's EPS TTM is $-0.255; its P/E ratio is -7.31; ATAI Life Sciences is scheduled to report earnings on May 13, 2024, and the estimated EPS forecast is $-0.18. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 18.00K	$ 87.00K	$ 172.00K	$ 37.00K	$ 39.00K
Gross Profit	$ 18.00K	$ 87.00K	$ 172.00K	$ 37.00K	$ 39.00K
EBIT	$ -17.63M	$ 44.53M	$ -31.00M	$ -33.77M	$ -34.62M
EBITDA	$ -17.43M	$ 44.71M	$ -30.83M	$ -33.63M	$ -34.44M
Net Income Common Stockholders	$ -18.36M	$ 44.28M	$ -33.04M	$ -33.17M	$ -45.05M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 45.03M	$ 76.49M	$ 141.09M	$ 185.88M	$ 190.61M
Total Assets	$ 293.48M	$ 308.22M	$ 253.59M	$ 279.60M	$ 305.44M
Total Debt	$ 16.04M	$ 16.26M	$ 16.29M	$ 16.29M	$ 14.70M
Net Debt	$ -29.00M	$ -60.23M	$ -124.81M	$ -169.60M	$ -175.91M
Total Liabilities	$ 49.16M	$ 39.71M	$ 37.96M	$ 40.08M	$ 39.67M
Stockholders Equity	$ 242.96M	$ 266.28M	$ 212.55M	$ 236.82M	$ 260.74M
Cash Flow	-
Free Cash Flow	$ -21.97M	$ -18.43M	$ -22.51M	$ -21.36M	$ -30.65M
Operating Cash Flow	$ -21.96M	$ -18.43M	$ -22.54M	$ -21.08M	$ -30.50M
Investing Cash Flow	$ -823.00K	$ -46.48M	$ -22.08M	$ 15.98M	$ 80.05M
Financing Cash Flow	$ -8.46M	-	$ -100.00K	$ 206.00K	$ -922.00K

Currency in USD

ATAI Life Sciences Earnings and Revenue History

Income Statement >

ATAI Life Sciences Debt to Assets

Balance Sheet >

ATAI Life Sciences Cash Flow

Cash Flow >

ATAI Life Sciences Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing